文献速递甲状腺疾病

分化型甲状腺癌门诊131I治疗后的辐射安全相关问题:交通与住宿

Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient 131I Therapy for Differentiated Thyroid Cancer.
PubMed 文献 · Thyroid · 2017-01-01

本研究通过电子邮件邀请超过15000名ThyCa成员参与网络调查,共1549例患者完成。结果显示45%(699/1541)的受访者未讨论住院或门诊治疗选择,5%(79/1541)由保险公司决定;97%(1459/1504)和93%(1351/1447)分别收到口头和书面辐射安全指导;88%(1208/1370)在给药后1小时内出院,97%(1334/1373)自驾离开;94%(1398/1488)居家或亲属家,5%(76/1488)住公共住宿。作者认为这些辐射安全问题需进一步讨论、制定指南和/或政策。

要点

  • 45%(699/1541)的受访者未讨论住院或门诊治疗选择,5%(79/1541)由保险公司决定。
  • 97%(1459/1504)和93%(1351/1447)的受访者分别收到口头和书面辐射安全指导。
  • 88%(1208/1370)在给药后1小时内出院,97%(1334/1373)自驾离开;94%(1398/1488)居家或亲属家,5%(76/1488)住公共住宿。

核心结论

  • 这是关于门诊131I治疗辐射安全方面最大的患者调查,提示在住院与门诊决策过程、辐射安全指导、交通和住宿等方面存在担忧,需进一步讨论、制定指南和/或政策。

研究设计与样本

  • 通过电子邮件邀请超过15000名ThyCa成员参与网络调查,共1549例患者完成,调查其最近一次门诊131I治疗的辐射安全相关问题。

主要发现

  • 45%(699/1541)的受访者未讨论住院或门诊治疗选择,5%(79/1541)由保险公司决定。
  • 97%(1459/1504)和93%(1351/1447)的受访者分别收到口头和书面辐射安全指导;核医学医生提供口头和书面指导的比例分别为54%(807/1504)和41%(602/1462)。
  • 88%(1208/1370)在给药后1小时内出院,97%(1334/1373)自驾离开治疗机构。
  • 治疗后立即,94%(1398/1488)居家或亲属家,5%(76/1488)住公共住宿;99%(1451/1467)认为遵守了指导。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether radioactive iodine (131I) treatments for differentiated thyroid cancer should be performed as an outpatient or inpatient remains controversial. The objective of this study was to survey selected aspects of radiation safety of patients treated with 131I for differentiated thyroid cancer as an outpatient. METHODS: An e-mail invitation was sent to over 15,000 members of ThyCa: Thyroid Cancer Survivors' Association, Inc. to complete a web-based survey on selected aspects of radiation safety regarding their last outpatient 131I treatment. RESULTS: A total of 1549 patients completed the survey. Forty-five percent (699/1541) of the respondents reported no discussion on the choice of an inpatient or outpatient treatment. Moreover, 5% (79/1541) of the respondents reported that their insurance company made the decision. Survey respondents recalled receiving oral and written radiation safety instructions 97% (1459/1504) and 93% (1351/1447) of the time, respectively. Nuclear medicine physicians delivered oral and written instructions to 54% (807/1504) and 41% (602/1462) of the respondents, respectively. Eighty-eight percent (1208/1370) of the respondents were discharged within 1 hour after receiving their 131I treatment, and 97% (1334/1373) traveled in their own car after being released from the treating facility. Immediately post-therapy, 94% (1398/1488) of the respondents stayed at their own home or a relative's home, while 5% (76/1488) resided in a public lodging. The specific recommendations received by patients about radiation precautions varied widely among the respondents. Ninety-nine percent (1451/1467) of the respondents believed they were compliant with the instructions. CONCLUSION: This is the largest, patient-based survey published regarding selected radiation safety aspects of outpatient 131I treatment. This survey suggests several concerns about radiation safety, such as the decision process regarding inpatient versus outpatient treatment, instructions about radiation safety, transportation, and lodging after radioiodine therapy. These concerns warrant further discussion, guidelines, and/or policies.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Gomes-Lima CJ, Wu D, Kharazi PH, et al. Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient 131I Therapy for Differentiated Thyroid Cancer. Thyroid. 2017. PMID: 29132255. doi:10.1089/thy.2017.0124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。